152 results match your criteria: "Baylor School of Medicine[Affiliation]"
JACC Adv
December 2024
Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan UCLA Medical Center, Los Angeles, California, USA.
BAY 2413555 is a novel selective and reversible positive allosteric modulator of the type 2 muscarinic acetylcholine (M2) receptor, aimed at enhancing parasympathetic signaling and restoring cardiac autonomic balance for the treatment of heart failure (HF). This study tested the safety, tolerability and pharmacokinetics of this novel therapeutic option. REMOTE-HF was a multicenter, double-blind, randomized, placebo-controlled, phase Ib dose-titration study with two active arms.
View Article and Find Full Text PDFPerspect Med Educ
December 2024
Department of Education, Innovation, and Technology, Baylor School of Medicine and Assistant Dean for Medical Education Research, US.
Background & Need For Innovation: Objective Structured Clinical Examinations (OSCEs) are commonly employed to assess clinical skills. While several existing tools address components of clinical reasoning, including the Assessment of Reasoning Tool, none are calibrated for competency-based assessment of medical students (UME) in an OSCE setting.
Goal Of Innovation: We sought to create a clinical reasoning assessment for use in a high-stakes, summative medical student OSCE.
Am J Perinatol
November 2024
Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, Texas.
Objective: This study aimed to compare the composite maternal hemorrhagic outcomes (CMHOs) among term (≥37 weeks) singletons who had scheduled versus unscheduled cesarean deliveries (CDs). A subgroup analysis was done for those without prior uterine surgeries.
Study Design: Retrospectively, we identified all singletons at term who had CDs.
Am J Lifestyle Med
September 2024
Division of Cardiology, Department of Medicine, National Jewish Health, Denver, CO, USA (AMF).
Cardiovascular disease (CVD) and cardiometabolic risk (CMR) are highly prevalent globally. The interplay between CVD/CMR and COVID-19 morbidity and mortality has been intensely studied over the last three years and has yielded some important discoveries and warnings for public health. Despite many advances in cardiovascular medicine, CVD continues to be the global leading cause of death.
View Article and Find Full Text PDFBackground: As future cardiovascular disease mortality trends have public health implications, we aimed to project ischemic heart disease (IHD), cerebrovascular disease (CeVD), and heart failure (HF) mortality rates for adults (40-79 years).
Methods And Results: In this population-level study, we linked the yearly mortality rates (per 100 000 US residents) (2000-2019) with IHD, CeVD, or HF as the primary cause of death from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research with the midyear US population estimates (2000-2035) for adults (40-79 years). We calculated the observed age-standardized mortality rates (2000-2019) (per 100 000 residents) (aSMR) and fitted Bayesian age-period-cohort models to project aSMR for IHD, CeVD, and HF up to 2035 in the United States.
Clin Orthop Relat Res
January 2025
Professor of Orthopedic Surgery, Baylor School of Medicine and Chief of International and Destination Surgery, Texas Children's Hospital, Houston, TX, USA.
J Neurosurg
October 2024
3Neuroendovascular Program, Massachusetts General Hospital & Brigham and Women's Hospital, Harvard University, Boston, Massachusetts.
J Pediatr Orthop
February 2025
Department of Orthopaedics, Washington University School of Medicine, St. Louis, MO.
Orphanet J Rare Dis
August 2024
Mun-H-Center, National Orofacial Resource Centre for Rare Diseases and Clinic of Pedodontics, Public Dental Service, Region Västra Götaland, Göteborg, Sweden.
Background: Osteogenesis imperfecta (OI) is a group of inherited connective tissue disorders of varying severity characterized by bone fragility. The primary objective of this international multidisciplinary collaboration initiative was to reach a consensus for a standardized set of clinician and patient-reported outcome measures, as well as associated measuring instruments for dental care of individuals with OI, based on the aspects considered important by both experts and patients. This project is a subsequent to the Key4OI project initiated by the Care4BrittleBones foundation which aims to develop a standard set of outcome measures covering a large domain of factors affecting quality of life for people with OI.
View Article and Find Full Text PDFInterv Neuroradiol
August 2024
Neuroendovascular Program, Massachusetts General Hospital & Brigham and Women's Hospital, Harvard University, Boston, MA, USA.
Neurosurg Rev
July 2024
Neuroendovascular Program, Massachusetts General Hospital & Brigham and Women's Hospital, Harvard University, Boston, MA, USA.
J Stroke Cerebrovasc Dis
November 2024
Department of Neurosurgery and Interventional Neuroradiology, Louisiana State University, Shreveport, LA, USA; Department of Neuroradiology, Massachusetts General Hospital & Brigham and Women's Hospital, Boston, MA, USA.
AJNR Am J Neuroradiol
July 2024
Division of Diagnostic and Therapeutic Neuroradiology, Department of Radiology, St. Michael's Hospital (J.D.B.D., N.M.C., J.S., V.M.P., A.A.D.), University of Toronto, Toronto, Ontario, Canada
Radiol Cardiothorac Imaging
June 2024
From the Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, Calif (S.G.); Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Ill (S.G.); Department of Nuclear Medicine, Peter Lougheed Hospital, Alberta Health Services, Calgary, Canada (A.S.K.); Department of Radiology, University of Calgary, Calgary, Canada (A.S.K.); Department of Radiology & Medical Imaging, University of Virginia, Charlottesville, Va (T.B.); Department of Radiology, Texas Children's Hospital, Baylor School of Medicine, Houston, Tex (J.G.); Division of Cardiology, University Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia (E.P.); OhioHealth, Columbus, Ohio (S.V.R.); Langley Memorial Hospital, British Columbia, Canada (E.L.); Department of Biomedical Imaging Science, University of Leeds, Leeds, United Kingdom (M.M.B.); Cardiac Center, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia (M.A.); Cardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (A.E.C.W.); Joint Department of Medical Imaging, Peter Munk Cardiac Centre and Toronto General Hospital Research Institute, University Medical Imaging Toronto, University Health Network (UHN), 585 University Avenue, 1 PMB-298, Toronto, ON, Canada M5G 2N2 (K.H.); and Department of Medical Imaging, University of Toronto, Toronto, Canada (K.H.).
Environmental exposures including poor air quality and extreme temperatures are exacerbated by climate change and are associated with adverse cardiovascular outcomes. Concomitantly, the delivery of health care generates substantial atmospheric greenhouse gas (GHG) emissions contributing to the climate crisis. Therefore, cardiac imaging teams must be aware not only of the adverse cardiovascular health effects of climate change, but also the downstream environmental ramifications of cardiovascular imaging.
View Article and Find Full Text PDFActa Ortop Mex
June 2024
Baylor School of Medicine, Department of Pediatric Orthopedic Surgery, Texas Children's Hospital. USA.
Arthrofibrosis is a challenging complication associated with knee injuries in both children and adults. While much is known about managing arthrofibrosis in adults, it is necessary to understand its unique aspects and management strategies in the pediatric population. This paper provides an overview of arthrofibrosis in pediatric orthopedic surgery, focusing on its causes, implications, classifications, and management.
View Article and Find Full Text PDFCurr Cardiol Rep
July 2024
Division of Cardiothoracic Surgery, Houston Methodist DeBakey Heart & Vascular Center, Allison Family Distinguished Chair of Cardiovascular Research, 6550 Fannin Street, Office 1401, Houston, TX, 77030, USA.
Purpose Of Review: This review explores the epidemiology, clinical traits, and diagnosis of Transcatheter Aortic Valve Replacement-Associated Infective Endocarditis (TAVR-IE) and mitral transcatheter edge-to-edge repair infective endocarditis (TEER-IE), focusing on a multimodal imaging approach. It addresses the rising prevalence of TAVR and TEER, emphasizing the need to understand long-term complications and clinical consequences, which poses significant challenges despite advancements in valve technology.
Recent Findings: Studies report a variable incidence of TAVR-IE and TEER-IE influenced by diverse patient risk profiles and procedural factors.
J Neurosurg
October 2024
3Neuroendovascular Program, Massachusetts General Hospital and Brigham and Women's Hospital, Harvard University, Boston, Massachusetts.
Urology
July 2024
Oakland University William Beaumont School of Medicine, Rochester, MI; Corewell Health William Beaumont University Hospital, Royal Oak, MI. Electronic address:
Objective: To improve diagnosis of interstitial cystitis (IC)/bladder pain syndrome(IC) we hereby developed an improved IC risk classification using machine learning algorithms.
Methods: A national crowdsourcing resulted in 1264 urine samples consisting of 536 IC (513 female, 21 male, 2 unspecified), and 728 age-matched controls (318 female, 402 male, 8 unspecified) with corresponding patient-reported outcome (PRO) pain and symptom scores. In addition, 296 urine samples were collected at three academic centers: 78 IC (71 female, 7 male) and 218 controls (148 female, 68 male, 2 unspecified).
Background: Pulmonary hypertension (PH) and secondary mitral regurgitation (MR) are associated with adverse outcomes after mitral transcatheter edge-to-edge repair. We aim to study the prognostic value of invasively measured right ventricular afterload in patients undergoing mitral transcatheter edge-to-edge repair.
Methods And Results: We identified patients who underwent right heart catheterization ≤1 month before transcatheter edge-to-edge repair.
Neurosurg Rev
March 2024
Departement of Neurosurgery and Interventional Neuroradiology, Louisiana State University, Shreveport, LA, USA.
Background: The Woven EndoBridge (WEB) devices have been used for treating wide neck bifurcation aneurysms (WNBAs) with several generational enhancements to improve clinical outcomes. The original device dual-layer (WEB DL) was replaced by a single-layer (WEB SL) device in 2013. This study aimed to compare the effectiveness and safety of these devices in managing intracranial aneurysms.
View Article and Find Full Text PDFBackground: Prior studies investigating the impact of residual mitral regurgitation (MR), tricuspid regurgitation (TR), and elevated predischarge transmitral mean pressure gradient (TMPG) on outcomes after mitral transcatheter edge-to-edge repair (TEER) have assessed each parameter in isolation. We sought to examine the prognostic value of combining predischarge MR, TR, and TMPG to study long-term outcomes after TEER.
Methods And Results: We reviewed the records of 291 patients who underwent successful mitral TEER at our institution between March 2014 and June 2022.
Circ Cardiovasc Qual Outcomes
March 2024
BHF Cardiovascular Research Center, School of Cardiovascular and Metabolic Health (M.C.P., N.S.), University of Glasgow, United Kingdom.
Background: Patients with type 2 diabetes are at risk of heart failure hospitalization. As social determinants of health are rarely included in risk models, we validated and recalibrated the WATCH-DM score in a diverse patient-group using their social deprivation index (SDI).
Methods: We identified US Veterans with type 2 diabetes without heart failure that received outpatient care during 2010 at Veterans Affairs medical centers nationwide, linked them to their SDI using residential ZIP codes and grouped them as SDI <20%, 21% to 40%, 41% to 60%, 61% to 80%, and >80% (higher values represent increased deprivation).
J Neurointerv Surg
December 2024
Department of Neurosurgery and Interventional Neuroradiology, Louisiana State University, Shreveport, LA, USA.
Digit Health
November 2023
Department of Urology, Oakland University William Beaumont School of Medicine, Rochester, MI, USA.
Introduction: Interstitial cystitis/bladder pain syndrome (IC/BPS) manifests as urinary symptoms including urgency, frequency, and pain. The IP4IC Study aimed to establish a urine-based biomarker score for diagnosing IC/BPS. To accomplish this objective, we investigated the parallels and variances between patients enrolled via physician/hospital clinics and those recruited through online crowdsourcing.
View Article and Find Full Text PDF